Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Harbin Medisan Pharmaceutical Co., Ltd.
—
Harbin Medisan Pharmaceutical Co., Ltd. is led by CEO Jian Fei Qin, employs 2,086 people, headquartered in Harbin, CN, publicly traded since 2017.
Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) stock trades at $10.25 with a market capitalization of $3.71B. The stock is valued at a negative price-to-earnings (P/E) ratio of -13.84, reflecting a net loss over the last twelve months, price-to-book of 2.14, price-to-sales of 4.61. Over the past 52 weeks the stock has ranged between $8.93 and $17.19, and currently trades 40.4% below its 52-week high.
On profitability, Harbin Medisan Pharmaceutical Co., Ltd. generates a return on equity (ROE) of -15.66% (negative, reflecting a net loss), an operating margin of -15.40%, a net profit margin of -36.20%.
Official website: www.medisan.com.cn
Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) — frequently asked questions
What is Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) stock price today?
Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) is currently trading at $10.25, down 4.92% today.
What is 002900.SZ P/E ratio?
Harbin Medisan Pharmaceutical Co., Ltd.'s P/E ratio is -13.84. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 002900.SZ return on equity (ROE)?
Harbin Medisan Pharmaceutical Co., Ltd.'s return on equity (ROE) is -15.66%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Harbin Medisan Pharmaceutical Co., Ltd.'s market cap?
Harbin Medisan Pharmaceutical Co., Ltd. has a market capitalization of $3.71B.
Does 002900.SZ pay a dividend?
Harbin Medisan Pharmaceutical Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 002900.SZ carry?
Harbin Medisan Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.52. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002900.SZ's profit margin?
Harbin Medisan Pharmaceutical Co., Ltd. reports a net profit margin of -36.20% — the share of revenue left after every cost, including tax and interest.
What sector is 002900.SZ in?
Harbin Medisan Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002900.SZ listed on?
Harbin Medisan Pharmaceutical Co., Ltd. trades on SHZ under the ticker 002900.SZ.
What is 002900.SZ's 52-week range?
Over the last year Harbin Medisan Pharmaceutical Co., Ltd. has traded between $8.93 and $17.19.
Related — Stocks
Popular Stocks
Screens 002900.SZ currently matches
On the figures above, Harbin Medisan Pharmaceutical Co., Ltd. passes the filters for 5 of our ready-made screens, among them Stocks Under $100, Stocks Under $50, Mid Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.